|
ZBED5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.694600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.584800E-01 |
| Normal-vs-Stage2 |
8.644000E-01 |
| Normal-vs-Stage3 |
3.631400E-01 |
| Normal-vs-Stage4 |
9.031500E-02 |
| Stage1-vs-Stage2 |
7.292000E-01 |
| Stage1-vs-Stage3 |
5.136000E-02 |
| Stage1-vs-Stage4 |
3.976200E-03 |
| Stage2-vs-Stage3 |
4.604200E-01 |
| Stage2-vs-Stage4 |
2.159600E-01 |
| Stage3-vs-Stage4 |
4.284800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.286000E-01 |
| Normal-vs-AfricanAmerican |
2.676200E-01 |
| Normal-vs-Asian |
3.659200E-01 |
| Caucasian-vs-AfricanAmerican |
1.488640E-01 |
| Caucasian-vs-Asian |
4.340800E-01 |
| AfricanAmerican-vs-Asian |
8.280000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.669600E-01 |
| Normal-vs-Female |
2.554000E-01 |
| Male-vs-Female |
2.552200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.499000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.540800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.983400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.754800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.675800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.796800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.438400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.979600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.430200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.553600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.794150E-02 |
| Normal-vs-Grade 2 |
9.277700E-02 |
| Normal-vs-Grade 3 |
4.063600E-01 |
| Normal-vs-Grade 4 |
9.041000E-04 |
| Grade 1-vs-Grade 2 |
2.912600E-01 |
| Grade 1-vs-Grade 3 |
7.577500E-03 |
| Grade 1-vs-Grade 4 |
8.28750000000378E-05 |
| Grade 2-vs-Grade 3 |
2.663400E-03 |
| Grade 2-vs-Grade 4 |
1.99140000045617E-07 |
| Grade 3-vs-Grade 4 |
2.384500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.984200E-03 |
| Normal-vs-ccB subtype |
3.652000E-02 |
| ccA subtype-vs-ccB subtype |
9.98500000459757E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.098600E-01 |
| Normal-vs-N1 |
1.779840E-02 |
| N0-vs-N1 |
5.053600E-02 |
|
|
